Struggling With Hair Loss?
Let's face it, losing your hair is unwelcomed proposition. Your hair is one of your more distinguishing physical features; your hair defines your personality. That's why Viviscal Shampoos and products are so important and are recommend by Doctors to individuals that are experiencing thinning or patchy hair loss. Viviscal hair rejuvenation products are 100% drug free and have shown proven results for both men and women during independent studies.
It's Official! Independent Study Confirms Users are Highly Satisfied with the REGROWTH of their hair.
What was treated in the study: Treatment of Alopecia Areata, Alopecia Totalis and Alopecia Universalis with Oral Viviscal for 12 months
Commission members include: Swedish Alopecia Association, administrated by B. Prästbacka (chairman) and Patricia Brosdotter-Johansson (vice chairman)
Authentication of the study: The study was clinically monitored by M. Majass (md) and O. Puuste (md) and Department of Dermatology, Central Hospital, Tallinn, Estonia, 1994
Viviscal Hair Growth Summery
Altogether 97 members of the Swedish Alopecia Association (RFH) with eitheralopecia areata, alopecia totalis or alopecia universalis volunteered to take part in a 12 months study to assess the effect of oral Viviscal on regrowth of scalp hair. Thirteen patients withdrew after 3 - 4 months because of lack of effect of the treatment. The remaining 84 patients fulfilled the treatment and were therefore valuable.
Fifty of these had alopecia areata, 12 alopecia totalis and 22 alopecia universalis. They all took two tablets of Viviscal daily for 12 months. Before the study, after 6 and 12 months they fulfilled a questionnaire regarding the start of regrowth of scalp hair and the estimated area of the scalp with regrowth of permanent hair. In the areata group regrowth of permanent hair started to appear after approximately 6 months in 46 patients, in the totalis group in 10 patients after 4 months and in the universalis group after 5 months in 7 patients.
After 12 months, 7 patients in the areata group (14%) showed complete regrowth of hair, 27 patients estimated a regrowth of 70 - 95%, 10 a regrowth of 50 - 65% and 6 a regrowth less than 50%.
In the totalis group 3 patients had a complete hair regrowth, 3 a regrowth of 70 - 95%, 4 a regrowth of 50 - 65% and 3 a regrowth of hair less than 50%. In the alopecia universalis group one of the patients reported complete regrowth of hair, 4 had a regrowth of 70 -95% and one a regrowth of 50 - 65%, while 16 had less than 50% regrowth of scalp hair. Better nail growth was reported by all patients with weak nails prior to the study.
Overall 34 patients (68%) of the patients in the alopecia areata group, 6 of the patients (50%) of the patients in the alopecia totalis group and 5 patients (23%) in the alopecia universalis group were highly satisfied with the treatment results, while 10 (20%), 4 (33%) and 1 (5%), respectively estimated the end result as good.
Buy Your Viviscal Products For Less At ActiveForever!
There was a noteworthy correlation between the treatment results and the type of alopecia, but no significant connection between the age and sex of the patients or duration of hair loss could be observed. No adverse responses or unexpected events were reported by the patients.
ActiveForever is one of the top ranked web businesses and one of the most successful print catalog/print educational materials businesses in the country.
You can visit our website at http://www.activeforever.com or call us toll free at 1-800-377-8033
It's Official! Independent Study Confirms Users are Highly Satisfied with the REGROWTH of their hair.
What was treated in the study: Treatment of Alopecia Areata, Alopecia Totalis and Alopecia Universalis with Oral Viviscal for 12 months
Commission members include: Swedish Alopecia Association, administrated by B. Prästbacka (chairman) and Patricia Brosdotter-Johansson (vice chairman)
Authentication of the study: The study was clinically monitored by M. Majass (md) and O. Puuste (md) and Department of Dermatology, Central Hospital, Tallinn, Estonia, 1994
Viviscal Hair Growth Summery
Altogether 97 members of the Swedish Alopecia Association (RFH) with eitheralopecia areata, alopecia totalis or alopecia universalis volunteered to take part in a 12 months study to assess the effect of oral Viviscal on regrowth of scalp hair. Thirteen patients withdrew after 3 - 4 months because of lack of effect of the treatment. The remaining 84 patients fulfilled the treatment and were therefore valuable.
Fifty of these had alopecia areata, 12 alopecia totalis and 22 alopecia universalis. They all took two tablets of Viviscal daily for 12 months. Before the study, after 6 and 12 months they fulfilled a questionnaire regarding the start of regrowth of scalp hair and the estimated area of the scalp with regrowth of permanent hair. In the areata group regrowth of permanent hair started to appear after approximately 6 months in 46 patients, in the totalis group in 10 patients after 4 months and in the universalis group after 5 months in 7 patients.
After 12 months, 7 patients in the areata group (14%) showed complete regrowth of hair, 27 patients estimated a regrowth of 70 - 95%, 10 a regrowth of 50 - 65% and 6 a regrowth less than 50%.
In the totalis group 3 patients had a complete hair regrowth, 3 a regrowth of 70 - 95%, 4 a regrowth of 50 - 65% and 3 a regrowth of hair less than 50%. In the alopecia universalis group one of the patients reported complete regrowth of hair, 4 had a regrowth of 70 -95% and one a regrowth of 50 - 65%, while 16 had less than 50% regrowth of scalp hair. Better nail growth was reported by all patients with weak nails prior to the study.
Overall 34 patients (68%) of the patients in the alopecia areata group, 6 of the patients (50%) of the patients in the alopecia totalis group and 5 patients (23%) in the alopecia universalis group were highly satisfied with the treatment results, while 10 (20%), 4 (33%) and 1 (5%), respectively estimated the end result as good.
Buy Your Viviscal Products For Less At ActiveForever!
There was a noteworthy correlation between the treatment results and the type of alopecia, but no significant connection between the age and sex of the patients or duration of hair loss could be observed. No adverse responses or unexpected events were reported by the patients.
ActiveForever is one of the top ranked web businesses and one of the most successful print catalog/print educational materials businesses in the country.
You can visit our website at http://www.activeforever.com or call us toll free at 1-800-377-8033
